Medicare AdvantageNovember 30, 2021
Adjudicating claims for COVID-19 vaccines, their administration and COVID-19 monoclonal antibodies
Beginning January 1, 2024, Empire became Anthem. This article, published under the former brand, now applies to Anthem.
Beginning January 1, 2022, Medicare Advantage Organizations (MAOs) and Medicare-Medicaid Plans (MMPs) are responsible for adjudicating claims for COVID-19 vaccines and their administration and for
COVID-19 monoclonal antibodies and their administration.
COVID-19 monoclonal antibodies and their administration.
PUBLICATIONS: December 2021 Newsletter
To view this article online:
Or scan this QR code with your phone